We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$34.7B
Cap. Flow
% of AUM
-172.71%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$75M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$66.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$64.8M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$50.3M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.53B |
| 2 |
Microsoft
MSFT
|
+$1.91B |
| 3 |
Apple
AAPL
|
+$1.42B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Meta Platforms (Facebook)
META
|
+$836M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1451
Chatham Lodging
CLDT
$601M
| $11.6K | ﹤0.01% |
1,408
-20,783
| -94% | -$187K |
|
1452
Precigen
PGEN
$2.32B
| $11.4K | ﹤0.01% |
+7,536
| New | +$10.9K |
|
|
OLP
1453
One Liberty Properties
OLP
$537M
| $11.3K | ﹤0.01% |
+490
| New | +$11.3K |
|
1454
Pacific Biosciences
PACB
$357M
| $11.1K | ﹤0.01% |
8,131
-1,327,731
| -99% | -$2.68M |
|
|
PKST
1455
DELISTED
Peakstone Realty Trust
PKST
| $10.9K | ﹤0.01% |
+1,047
| New | +$13.8K |
|
1456
Anavex Life Sciences
AVXL
$303M
| $10.8K | ﹤0.01% |
2,527
-52,323
| -95% | -$212K |
|
1457
Zillow
ZG
$8.15B
| $10.8K | ﹤0.01% |
+238
| New | +$10.3K |
|
1458
Autoliv
ALV
$8.89B
| $10.6K | ﹤0.01% |
+100
| New | +$11.9K |
|
1459
Cabaletta Bio
CABA
$442M
| $10.6K | ﹤0.01% |
1,441
-10,539
| -88% | -$129K |
|
1460
Lyell Immunopharma
LYEL
$337M
| $10.5K | ﹤0.01% |
+381
| New | +$18.1K |
|
1461
Phibro Animal Health
PAHC
$1.38B
| $10.4K | ﹤0.01% |
+607
| New | +$9.76K |
|
|
TRML
1462
DELISTED
Tourmaline Bio
TRML
| $10.1K | ﹤0.01% |
+766
| New | +$12.3K |
|
1463
Vanda Pharmaceuticals
VNDA
$304M
| $10.1K | ﹤0.01% |
1,738
-26,130
| -94% | -$135K |
|
1464
Liberty Live Group Series C
LLYVK
$9.92B
| $10K | ﹤0.01% |
+274
| New | +$10.6K |
|
1465
Xeris Biopharma Holdings
XERS
$1.52B
| $10K | ﹤0.01% |
+4,426
| New | +$8.92K |
|
1466
ALX Oncology
ALXO
$268M
| $9.07K | ﹤0.01% |
1,555
-9,382
| -86% | -$115K |
|
|
AMK
1467
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $8.91K | ﹤0.01% |
258
-11,601
| -98% | -$400K |
|
1468
Zentalis Pharmaceuticals
ZNTL
$297M
| $8.9K | ﹤0.01% |
2,120
-29,467
| -93% | -$329K |
|
1469
Nautilus Biotechnolgy
NAUT
$113M
| $8.53K | ﹤0.01% |
+3,740
| New | +$9.77K |
|
1470
Atea Pharmaceuticals
AVIR
$406M
| $8.5K | ﹤0.01% |
2,515
-27,950
| -92% | -$104K |
|
|
CBL
1471
CBL Properties
CBL
$1.78B
| $8.48K | ﹤0.01% |
372
-11,456
| -97% | -$253K |
|
|
AMRN
1472
Amarin Corp
AMRN
$299M
| $8.37K | ﹤0.01% |
597
-2,756
| -82% | -$47.4K |
|
1473
PagSeguro Digital
PAGS
$2.43B
| $8.28K | ﹤0.01% |
708
-276,160
| -100% | -$3.39M |
|
1474
MeiraGTx Holdings
MGTX
$1.17B
| $8.12K | ﹤0.01% |
1,920
-12,457
| -87% | -$62.9K |
|
|
RVNC
1475
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.04K | ﹤0.01% |
3,118
-34,500
| -92% | -$118K |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2024 Portfolio in Review
As of Q2 2024, Mirae Asset Global Investments held 2,693 positions worth $20.1B, down 56% from $46.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments withdrew a net $34.7B in Q2 2024, closing 1,170 positions and reducing 1,071 holdings. Its most notable exit was Vanguard Russell 2000 ETF, an estimated $449M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Mirae Asset Global Investments opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $15.6M.
- Mirae Asset Global Investments's largest Q2 2024 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $15.6M.
- Mirae Asset Global Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $75M increase.
- Mirae Asset Global Investments's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.53B.
- Mirae Asset Global Investments fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $449M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $20.1B portfolio in Q2 2024.
- Mirae Asset Global Investments opened 259 new positions and closed 1,170 in Q2 2024.
- Mirae Asset Global Investments's portfolio value fell 56% quarter-over-quarter to $20.1B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.